Post-market Surveillance of AI medical devices

Skin Analytics joins the Royal Society of Medicine, Digital Health Section podcast to discuss all things post-market surveillance

In this episode of the Royal Society of Medicine RSM Digital Health Section podcast, our Medical Director, Dr Dan Mullarkey discusses the pragmatic realities of conducting post-market surveillance for AI medical devices with Dr Annabelle Painter.

In the conversation you’ll hear Dan explain how Skin Analytics have tackled some difficult questions such as:

📊 How do you decide the appropriate accuracy levels of an AI device?
🔢 How can you access necessary outcome data from NHS organisations?
🏥 How does real world data analysis compare to traditional research studies?

More on Skin Analytics’ post-market surveillance.

Subscribe to our news updates

We won't spam
you, we promise.